Saturday, November 7, 2014

HALL B

08:30-10:30 

Hemophilia and factor XI deficiency

Chairpersons

Claude Negrier, France
Edward Tuddenham, UK

08:30-08:50

 State of the Art: Treatment of women with rare bleeding disorders: Current perspectives
 Paula Bolton-Maggs, UK

08:50-09:40
08:50
09:10
09:30

 Debate: Factor XI patients should receive replacement prior to delivery
 Yes: Paula Bolton-Maggs, UK
 No: Ophira Salomon, Israel
 Discussion 

09:40-10:30

09:40
10:00
10:20

Debate: Future standard care of adults with hemophilia would be new longer acting concentrates, applied for bleeding prophylaxis and surgery
Yes: Claude Negrier, France
No: Edward Tuddenham, UK
Discussion
 
 

HALL A

10:50-13:00

Acquired coagulopathies

Chairpersons

Pier M. Mannucci, Italy
Anna Falanga, Italy

10:50-11:45
10:50
11:10
11:30
DebateHow to handle invasive procedures in patients with chronic liver disease
The views of the haematologist: Pier M. Mannucci, Italy
The views of the hepatologist: Ton Lisman, Italy
Discussion
11:45-12:40
11:45
12:05
12:25
Debate: Is the platelet number a thrombosis risk factor in myeloproliferative neoplasms?
Yes: Gunnar Birgegard, Sweden
No: Anna Falanga, Italy
Discussion
12:40-12:50

Allo-, and autoantibody against Factor XIII a subunit.
The antibodies exerted multiple inhibitory effect on Factor XII activation/activity and resulted in severe bleeding with fatal outcome
László Muszbek, Hungary

12:50-13:00

Blood rheological properties and platelets hemostasis in cancer
Irina Tikhomirova, Russia


HALL B
14:00-15:40
Cancer bleeding and thrombosis
Chairpersons

Anna Falanga, Italy
Menno Huisman, The Netherlands

14:00-15:00
 
14:00
14:20
14:40
Debate: Is there a role for new oral anticoagulants in the treatment of venous thromboembolism in cancer patients?
Yes: Peter Verhamme, Belgium
No: Giancarlo Agnelli, Italy
Discussion
 15:00-15:20
State of the Art: Should incidental pulmonary embolism in cancer patients be treated as much
as symptomatic pulmonary embolism?
Menno Huisman, The Netherlands 
15:20-15:40
State of the Art: The role of coagulation proteins in cancer
Anna Falanga, Italy